InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.00
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
69,279.25
(
-0.04%
)
Post# of 253511
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: genisi post# 122938

Thursday, 07/07/2011 6:49:09 PM

Thursday, July 07, 2011 6:49:09 PM

Post# of 253511

So VRUS has all promising interferon-sparing combos: all nukes, nuke + NS5A, and now nuke+PI.

I wouldn't say that they have the latter two combos just yet. The deals with BMY and Tibotec are merely clinical trial collaborations. Assuming the trials yield results, I imagine some formal licensing deals will be struck afterwards between the companies, if one of them doesn't outright acquire VRUS.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up